WTAP and renal cell carcinoma: In addition, an increasing evidence has confirmed that WTAP plays crucial ontogenetic roles in various cancers, including gastric cancer, acute myelogenous leukemia, cholangiocarcinoma, colorectal cancer, glioma, pancreatic cancer, and renal cell carcinoma (14–20).